- Tel: 858.663.9055
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
ABO Antibodies reagents target the carbohydrate antigens of the ABO blood group system, the most clinically significant blood group in transfusion and transplantation medicine. The ABO system is defined by the presence of A, B, AB, or O antigens on the surface of red blood cells, with naturally occurring antibodies against absent antigens circulating in plasma.
The ABO system plays a central role in safe blood transfusion, organ transplantation, and hematology research. Incompatibility between donor and recipient ABO types leads to acute hemolytic transfusion reactions, making ABO typing the cornerstone of transfusion safety. Beyond transfusion medicine, ABO antigen expression has been linked to susceptibility to infection, cardiovascular disease, and cancer biology.
Because of these critical roles, the ABO Antibodies are indispensable for immunohematology, transfusion safety, immunology, and translational pipelines. The ABO Blood Group Antibodies portfolio complements these applications with reproducible detection across multiple platforms.
NSJ Bioreagents provides ABO Antibodies validated for immunohistochemistry (IHC), western blotting (WB), immunofluorescence (IF), flow cytometry (FACS), and ELISA. Each antibody undergoes rigorous quality control to ensure specificity, reproducibility, and clinical relevance.
Key benefits include:
Clinical Significance: Directly relevant to transfusion and transplantation biology.
Assay Versatility: Works across blood, tissue, and cell-based platforms.
Reproducibility: Batch-to-batch consistency supports longitudinal studies.
Comprehensive Documentation: Datasheets with validation images, protocols, and controls.
Translational Relevance: Suitable for biomarker research and clinical pipelines.
By choosing NSJ Bioreagents, researchers ensure their ABO Antibodies provide reliable, reproducible results for both laboratory and clinical applications.
The ABO Antibodies support wide-ranging applications in immunohematology, disease biology, and translational medicine.
Detect ABO antigen expression on red blood cells.
Support compatibility testing for safe transfusions.
Provide biomarkers for hemolytic transfusion reactions.
Extend into diagnostic transfusion safety pipelines.
ABO Antibodies detect incompatibility in transplantation.
Support graft compatibility studies in kidney, liver, and heart transplants.
Provide biomarkers for rejection risk assessment.
Extend into regenerative medicine and stem cell transplantation.
ABO antigen expression influences pathogen binding.
ABO Antibodies support studies linking blood group to infection outcomes.
Provide biomarkers for susceptibility to viral and bacterial diseases.
Extend into translational immunology research.
ABO blood group variants correlate with thrombosis risk.
ABO Antibodies detect blood group differences in clotting biology.
Provide biomarkers for cardiovascular disease susceptibility.
Extend into translational cardiology pipelines.
ABO antigen alterations observed in certain cancers.
ABO Antibodies support studies of tumor immune evasion.
Provide biomarkers for cancer progression and prognosis.
Extend into translational oncology pipelines.
Detect inheritance patterns of ABO blood groups.
Support anthropological and population genetics studies.
Provide markers for genetic linkage and epidemiology.
Extend into translational genetic research.
ABO Antibodies support studies of natural antibody development.
Clarify immune responses to non-self carbohydrate antigens.
Provide biomarkers for autoimmune and alloimmune disease.
Extend into translational immunology pipelines.
ABO Antibodies are vital for diagnostic assays in hospitals and clinics.
Provide reproducibility in typing and crossmatch assays.
Support biomarker-driven translational studies.
Bridge laboratory science with clinical diagnostics.
The ABO system is the most clinically important blood group, governing compatibility in transfusion and transplantation. The ABO Antibodies provide validated reagents for detecting ABO antigen expression and immune responses, enabling safe transfusion practices and advancing research.
In hematology, they safeguard transfusion compatibility. In transplantation, they reduce graft rejection risk. In infectious disease, they clarify host–pathogen dynamics. In oncology, they highlight tumor-associated antigen shifts. In cardiology, they reveal links between ABO blood groups and thrombosis.
Clinically, ABO typing is universal in medical practice. Reliable ABO Blood Group Antibodies ensure accuracy in diagnostics, research reproducibility, and translational value for patient care.
The ABO blood group system defines compatibility in transfusion and transplantation while influencing disease biology and immune function. The ABO Antibodies provide validated tools for transfusion medicine, immunology, cardiology, oncology, and translational research, while the ABO Blood Group Antibodies extend these applications with reproducibility across platforms. By ensuring specificity, reproducibility, and assay versatility, these antibodies remain indispensable for both basic science and clinical medicine.
IHC staining of FFPE human colon carcinoma tissue with Blood Group Antigen A / ABO antibody (Cat # V2550, clone HE-193).